drugset / Trial / NCT00762229

Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)

NCT00762229

Completed 39 enrolled Bronx VA Medical Center
RandomizedParallel-groupOpen-labelHealth-services research

Summary

The purpose of this study is to compare the effect on LDL cholesterol levels of converting patients who are receiving the cholesterol absorption inhibitor Zetia at a dose of 10 milligrams to 5 milligrams, when prescribed as a split 10 milligram tablet.

Timeline

Start
2007-07
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown 5 mg
Comparator Ezetimibe Unknown 10 mg

Indications